The Bureau of Tobacco Control of Health Canada intends to make Regulations pursuant to the Tobacco Act. This notice provides an opportunity to comment on proposed Tobacco Reporting Regulations. The purpose of these Regulations would be to set out the requirements for the reporting of sales data, manufacturing information, ingredients, toxic constituents, toxic emissions, research activities and promotional activities by manufacturers and importers. These regulations specify requirements for foodstuffs labelling. These regulations specify requirements for foodstuffs labelling.
Regulations specifies requirements for crystal glass labelling.
The purpose of this proposed amendment is to introduce proposed regulatory requirements for the sale and importation of drugs for use in human clinical trials. The new requirements would be located in Division 5 of the Food and Drug Regulations and would apply to clinical trials in humans using both new and old drugs. Consequential amendments would be required to Division 8 of the Regulations to maintain the status quo for clinical trials in animals using new veterinary drugs. The Bureau of Tobacco Control, Health Canada, intends to make Regulations pursuant to the Tobacco Act. This notice provides an opportunity to comment on proposed Tobacco Products Information Regulations.